KAKUYASU GROUP CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,131 JPY | -0.28% |
|
+0.42% | +21.77% |
| 2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- With a P/E ratio at 10.38 for the current year and 9.64 for next year, earnings multiples are highly attractive compared with competitors.
- The company shows low valuation levels, with an enterprise value at 0.2 times its sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Sector: Food Retail & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +21.77% | 126M | - | ||
| -0.77% | 6.2B | C | ||
| -1.64% | 1.02B | - | ||
| +10.14% | 415M | - | - | |
| +3.54% | 345M | - | - | |
| +0.66% | 215M | - | - | |
| -19.41% | 171M | - | - | |
| +9.89% | 102M | - | - | |
| -16.45% | 64.98M | - | - | |
| -26.19% | 53.16M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 7686 Stock
- Ratings Kakuyasu Group Co., Ltd.